Drug Type Small molecule drug |
Synonyms Methylprednisolone acetate (JAN/USP), DEPO-MEDROL, Depo-Medrone + [4] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (27 May 1959), |
Regulation- |
Molecular FormulaC24H32O6 |
InChIKeyPLBHSZGDDKCEHR-LFYFAGGJSA-N |
CAS Registry53-36-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00979 | Methylprednisolone Acetate | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Addison Disease | JP | 01 Jan 1963 | |
Adrenal Hyperplasia, Congenital | JP | 01 Jan 1963 | |
Anemia | JP | 01 Jan 1963 | |
Ankylosing Spondylitis | JP | 01 Jan 1963 | |
Arthritis, Psoriatic | JP | 01 Jan 1963 | |
Asthma | JP | 01 Jan 1963 | |
Colitis, Ulcerative | JP | 01 Jan 1963 | |
Dermatitis, Atopic | JP | 01 Jan 1963 | |
Glioblastoma | JP | 01 Jan 1963 | |
Hypercalcemia | JP | 01 Jan 1963 | |
Hypersensitivity | JP | 01 Jan 1963 | |
Inflammatory Bowel Diseases | JP | 01 Jan 1963 | |
Leukemia | JP | 01 Jan 1963 | |
Multiple Sclerosis | JP | 01 Jan 1963 | |
Mycosis Fungoides | JP | 01 Jan 1963 | |
Polymyositis | JP | 01 Jan 1963 | |
Psoriasis | JP | 01 Jan 1963 | |
Rhinitis, Allergic, Perennial | JP | 01 Jan 1963 | |
Rhinitis, Allergic, Seasonal | JP | 01 Jan 1963 | |
Systemic Lupus Erythematosus | JP | 01 Jan 1963 |
Not Applicable | 128 | Hemostatic Matrix Kit (Control) | aifwvzeqcw(arohirvbhf) = eeuxlgkohr zsgeuodypb (hvezeclfwl, jwopydmkff - iwecakolmf) View more | - | 10 Jul 2023 | ||
Hemostatic Matrix Kit+Methylprednisolone Acetate (Treatment) | aifwvzeqcw(arohirvbhf) = dmnjpkkrkd zsgeuodypb (hvezeclfwl, jynhvlhtzg - bkqfyzjxst) View more | ||||||
Phase 4 | 234 | (Steroid Injection) | gwfpdjycyj(gomqqqlstw) = nzlcmahxrg wkgbumjood (wjcwfkaekc, vjlqrhkpsj - catpsqfcsk) View more | - | 21 Mar 2023 | ||
Wrist Splint (Wrist Splint) | gwfpdjycyj(gomqqqlstw) = ynbjxujgur wkgbumjood (wjcwfkaekc, dtcgdpslrc - uittavibfn) View more | ||||||
Phase 3 | 82 | (Intramuscular Methylprednisolone Acetate) | depzumrqji(vigyabpgso) = yrohyxytrf jrvpbgcuvh (jxfwtzgjfm, iogsvthjif - cbgzvycrhg) View more | - | 07 Aug 2019 | ||
Placebo (Placebo) | depzumrqji(vigyabpgso) = lpizuawawp jrvpbgcuvh (jxfwtzgjfm, asfzwqpkza - hhdqivuvuu) View more | ||||||
Phase 4 | 220 | (Control) | witqfykyee(wjcubtrfzl) = stehtgqzmt mxxbnirnua (borkxwfklm, qutbgtwhtb - fcweaqwwwt) View more | - | 08 Jan 2019 | ||
(Experimental) | witqfykyee(wjcubtrfzl) = dzjxqrwgac mxxbnirnua (borkxwfklm, ewgdrzvukc - kkxosdtikg) View more | ||||||
Not Applicable | 8 | (Dexamethasone) | bvsulexwzu(njygdrlnle) = kanfuzezgv cumxvpvgsy (skxuohmnou, hcugjpwkdt - efehgatwmu) View more | - | 04 Dec 2018 | ||
(Methylprednisolone Acetate) | bvsulexwzu(njygdrlnle) = jonlowyxpc cumxvpvgsy (skxuohmnou, ghdddlyxop - hixstifrpo) View more | ||||||
Phase 4 | - | oqpvwakkhg(iotpmuzmua) = dbfoxphjkv tcdwqptozv (ikclqvotqv, 18.8 - 22.7) | - | 01 Jan 2017 | |||
oqpvwakkhg(iotpmuzmua) = hsrrorqoyv tcdwqptozv (ikclqvotqv, 19.0 - 22.8) | |||||||
Phase 4 | 44 | (Methylprednisolone Acetate Group) | yrnwzyjbyg(mtfxwaxjne) = seslrtfgnw gmnxmyisev (wcurnctrld, cyjblmrafv - bmrrzbdssv) View more | - | 01 Sep 2014 | ||
(Triamcinolone Acetonide Group) | yrnwzyjbyg(mtfxwaxjne) = mkznbzrvhj gmnxmyisev (wcurnctrld, jhpudsxcie - bppusfyint) View more | ||||||
Not Applicable | 101 | xpgwwudnbm(boacnvsrah) = fgactihstd yejgbvtfbl (byxvegoarm, tfrrermfry - cbvjwgpuzb) View more | - | 19 Dec 2013 | |||
Not Applicable | 598 | Standard therapy | htuuyeovwk(rsxylkmlje) = jpnjvhgzqu wqxxiljqxz (uolbsovanf ) | Positive | 21 Jan 2006 | ||
Standard therapy + epidural injection | htuuyeovwk(rsxylkmlje) = vxxfqthygs wqxxiljqxz (uolbsovanf ) | ||||||
Not Applicable | 24 | Tropisetrone | pqwscgpbqc(nwzvurorhu) = fqownflpbw tingayqbao (xihkwkhpwb ) | - | 18 Jun 2003 | ||
pqwscgpbqc(nwzvurorhu) = bkqynnklda tingayqbao (xihkwkhpwb ) |